Olr205 inhibitors represent a specialized class of chemical compounds that primarily target the Olr205 receptor, a G-protein-coupled receptor (GPCR) encoded by the OR gene family. This receptor belongs to the vast and diverse family of olfactory receptors, which are responsible for detecting a wide range of odorants in the environment. Olr205, like other olfactory receptors, is integral in the initial stages of the olfactory signal transduction pathway, which translates external chemical stimuli into neuronal signals that the brain interprets as specific smells. Inhibitors targeting Olr205 are designed to specifically interact with the active sites or allosteric regions of this receptor, thereby modulating its ability to bind with odorant molecules or altering the receptor's conformation and subsequent signal transduction. This modulation may be achieved through various mechanisms, including competitive inhibition, non-competitive inhibition, or allosteric modulation, depending on the chemical nature of the inhibitor and its interaction with the receptor.
The structural diversity of Olr205 inhibitors is significant, reflecting the complexity and specificity required to precisely target this receptor. These inhibitors are typically characterized by a high degree of selectivity for the Olr205 receptor, often necessitating intricate molecular designs that account for the receptor's unique binding pocket and conformational dynamics. The synthesis of these inhibitors involves advanced organic chemistry techniques, often requiring the construction of complex aromatic or heterocyclic frameworks that can mimic the structural motifs of natural ligands or disrupt receptor activity. The study and development of Olr205 inhibitors involve detailed structure-activity relationship (SAR) analyses to optimize binding affinity and specificity, alongside computational modeling to predict the most effective inhibitor conformations. The chemical properties of these inhibitors, including their solubility, stability, and reactivity, are meticulously evaluated to ensure that they effectively interact with Olr205 under various experimental conditions. Through this detailed and focused approach, researchers gain valuable insights into the molecular mechanisms underlying olfactory signal transduction, contributing to a broader understanding of olfactory receptor function.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Kinase inhibitor; indirectly impacts signaling pathways that could modulate Olr205. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Flavonoid with antioxidant properties; may alter cell signaling relevant to Olr205. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates various signaling pathways; potential indirect influence on Olr205. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Influences sirtuin pathways; could indirectly affect pathways related to Olr205. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR inhibitor; may affect signaling cascades indirectly linked to Olr205. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Influences Nrf2 pathway; may have an indirect role in modulating Olr205. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Estrogen receptor modulator; potentially impacts signaling pathways influencing Olr205. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor; could indirectly affect processes and pathways involving Olr205. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid; impacts a variety of signaling pathways, potentially affecting Olr205. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Bcr-Abl tyrosine kinase inhibitor; may indirectly influence pathways related to Olr205. | ||||||